Drug
Modakafusp Alfa
Modakafusp Alfa: highest development phase Phase 1/2, developed by Teva. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Teva
Trials
| Drug | Phase | Indication |
|---|---|---|
| Modakafusp Alfa NCT05590377 | Phase 1/2 | Multiple Myeloma |
Latest
No recent events.
Follow Modakafusp Alfa on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.